Menu
Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 13
Original Research
Empagliflozin in Type 2 Diabetes Mellitus Patients with High Cardiovascular Risk: A Model-Based Cost-Utility Analysis in China
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,867 | Dovepress* | 7,243+ | 1,003 | 8,246 | |
| PubMed Central* | 624 | 215 | 839 | ||
| Totals | 7,867 | 1,218 | 9,085 | ||
| *Since 11 August 2020 | |||||
View citations on PubMed Central and Google Scholar